Anhui Huangshan Capsule Co Ltd (002817) - Total Assets

Latest as of March 2026: CN¥1.12 Billion CNY ≈ $163.30 Million USD

Based on the latest financial reports, Anhui Huangshan Capsule Co Ltd (002817) holds total assets worth CN¥1.12 Billion CNY (≈ $163.30 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 002817 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Anhui Huangshan Capsule Co Ltd - Total Assets Trend (2011–2025)

This chart illustrates how Anhui Huangshan Capsule Co Ltd's total assets have evolved over time, based on quarterly financial data. See Anhui Huangshan Capsule Co Ltd (002817) net assets for net asset value and shareholders' equity analysis.

Anhui Huangshan Capsule Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Anhui Huangshan Capsule Co Ltd's total assets of CN¥1.12 Billion consist of 36.1% current assets and 63.9% non-current assets.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 14.0%
Accounts Receivable CN¥166.32 Million 15.0%
Inventory CN¥75.76 Million 6.8%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥17.13 Million 1.6%
Goodwill CN¥0.00 0.0%

Asset Composition Trend (2011–2025)

This chart illustrates how Anhui Huangshan Capsule Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Anhui Huangshan Capsule Co Ltd.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Anhui Huangshan Capsule Co Ltd's current assets represent 36.1% of total assets in 2025, a decrease from 63.1% in 2011.
  • Cash Position: Cash and equivalents constituted 14.0% of total assets in 2025, down from 14.8% in 2011.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2011.
  • Asset Diversification: The largest asset category is accounts receivable at 15.0% of total assets.

Anhui Huangshan Capsule Co Ltd Competitors by Total Assets

Key competitors of Anhui Huangshan Capsule Co Ltd based on total assets are shown below.

Company Country Total Assets
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
USA $15.42 Trillion
GALDERMA GROUP AG
NYSE:GALDY
USA $13.39 Billion
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
China CN¥19.57 Billion
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
China CN¥8.25 Billion
Beijing Winsunny Pharmaceutical CO.LTD
SHG:601089
China CN¥4.69 Billion
Akums Drugs and Pharmaceutical
NSE:AKUMS
India Rs51.59 Billion
Cronos Group Inc
TO:CRON
Canada CA$1.18 Billion
Tibet Weixinkang Medicine Co Ltd
SHG:603676
China CN¥1.95 Billion

Anhui Huangshan Capsule Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.08 3.98 5.05
Quick Ratio 2.49 3.31 4.31
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥254.28 Million CN¥442.72 Million CN¥470.28 Million

Anhui Huangshan Capsule Co Ltd - Advanced Valuation Insights

This section examines the relationship between Anhui Huangshan Capsule Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.52
Latest Market Cap to Assets Ratio 0.22
Asset Growth Rate (YoY) 2.0%
Total Assets CN¥1.11 Billion
Market Capitalization $246.85 Million USD

Valuation Analysis

Below Book Valuation: The market values Anhui Huangshan Capsule Co Ltd's assets below their book value (0.22x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Anhui Huangshan Capsule Co Ltd's assets grew by 2.0% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Anhui Huangshan Capsule Co Ltd (2011–2025)

The table below shows the annual total assets of Anhui Huangshan Capsule Co Ltd from 2011 to 2025.

Year Total Assets Change
2025-12-31 CN¥1.11 Billion
≈ $162.12 Million
+1.97%
2024-12-31 CN¥1.09 Billion
≈ $158.99 Million
-1.50%
2023-12-31 CN¥1.10 Billion
≈ $161.42 Million
+6.30%
2022-12-31 CN¥1.04 Billion
≈ $151.85 Million
-1.53%
2021-12-31 CN¥1.05 Billion
≈ $154.21 Million
+15.07%
2020-12-31 CN¥915.81 Million
≈ $134.01 Million
+10.10%
2019-12-31 CN¥831.80 Million
≈ $121.72 Million
+6.64%
2018-12-31 CN¥780.03 Million
≈ $114.14 Million
+5.59%
2017-12-31 CN¥738.73 Million
≈ $108.10 Million
+5.63%
2016-12-31 CN¥699.36 Million
≈ $102.34 Million
+69.34%
2015-12-31 CN¥413.00 Million
≈ $60.43 Million
+18.00%
2014-12-31 CN¥349.99 Million
≈ $51.22 Million
+7.34%
2013-12-31 CN¥326.07 Million
≈ $47.71 Million
+23.59%
2012-12-31 CN¥263.82 Million
≈ $38.61 Million
+33.14%
2011-12-31 CN¥198.15 Million
≈ $29.00 Million
--

About Anhui Huangshan Capsule Co Ltd

SHE:002817 China Drug Manufacturers - Specialty & Generic
Market Cap
$246.85 Million
CN¥1.69 Billion CNY
Market Cap Rank
#15601 Global
#4463 in China
Share Price
CN¥5.64
Change (1 day)
-1.57%
52-Week Range
CN¥5.64 - CN¥8.54
All Time High
CN¥62.96
About

Anhui Huangshan Capsule Co., Ltd. engages in the research and development, production, and sale of gelatin and enteric-coated gelatin empty capsules in China. The company offers pullulan capsules, entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colonsoluble vacant gelatin capsules, hydroxypropyl methyl cellulose hollow capsules, and hydroxypropyl st… Read more